Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-21

Clinical Trial Update: Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating combined Rg3-enriched Korean Red Ginseng and American Ginseng for managing hypertension in individuals with type 2 diabetes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rg3-enriched Korean Red Ginseng and American Ginseng combination

Snippet

Sponsor: Unity Health Toronto | Conditions: Diabetes Mellitus Type 2, Hypertension | Phase 1, Phase 2 | Status: COMPLETED